145 related articles for article (PubMed ID: 23482761)
1. The role of p16 expression as a predictive marker in HPV-positive oral SCCHN--a retrospective single-center study.
Geißler C; Tahtali A; Diensthuber M; Gassner D; Stöver T; Wagenblast J
Anticancer Res; 2013 Mar; 33(3):913-6. PubMed ID: 23482761
[TBL] [Abstract][Full Text] [Related]
2. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
3. Detection of HPV infection in head and neck squamous cell carcinoma: a practical proposal.
Dreyer JH; Hauck F; Oliveira-Silva M; Barros MH; Niedobitek G
Virchows Arch; 2013 Apr; 462(4):381-9. PubMed ID: 23503925
[TBL] [Abstract][Full Text] [Related]
4. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis.
Laco J; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Čelakovský P; Chrobok V; Mottl R; Mottlová A; Tuček L; Slezák R; Chmelařová M; Sirák I; Vošmik M; Ryška A
Virchows Arch; 2015 Oct; 467(4):405-15. PubMed ID: 26229021
[TBL] [Abstract][Full Text] [Related]
5. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
6. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
[TBL] [Abstract][Full Text] [Related]
9. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1.
Sgaramella N; Coates PJ; Strindlund K; Loljung L; Colella G; Laurell G; Rossiello R; Muzio LL; Loizou C; Tartaro G; Olofsson K; Danielsson K; Fåhraeus R; Nylander K
Br J Cancer; 2015 Jul; 113(2):321-6. PubMed ID: 26057450
[TBL] [Abstract][Full Text] [Related]
10. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
[TBL] [Abstract][Full Text] [Related]
11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
12. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
[TBL] [Abstract][Full Text] [Related]
13. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
14. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
15. p16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma.
Duncan LD; Winkler M; Carlson ER; Heidel RE; Kang E; Webb D
J Oral Maxillofac Surg; 2013 Aug; 71(8):1367-75. PubMed ID: 23642549
[TBL] [Abstract][Full Text] [Related]
16. Basaloid lesions of oral squamous epithelial cells and their association with HPV infection and P16 expression.
Friedrich RE; Sperber C; Jäkel T; Röser K; Löning T
Anticancer Res; 2010 May; 30(5):1605-12. PubMed ID: 20592349
[TBL] [Abstract][Full Text] [Related]
17. p16 and p53 in HPV-positive versus HPV-negative oral squamous cell carcinoma: do pathways differ?
Singh V; Husain N; Akhtar N; Khan MY; Sonkar AA; Kumar V
J Oral Pathol Med; 2017 Oct; 46(9):744-751. PubMed ID: 28186650
[TBL] [Abstract][Full Text] [Related]
18. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
19. Impact of human papilloma virus in patients with oral and oropharyngeal squamous cell carcinomas.
Valls-Ontañón A; Hernández-Losa J; Somoza Lopez de Haro R; Bellosillo-Paricio B; Ramón Y Cajal S; Bescós-Atín C; Munill-Ferrer M; Alberola-Ferranti M
Med Clin (Barc); 2019 Mar; 152(5):174-180. PubMed ID: 30777194
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
